Skip to main content

We are committed to doing all we can to respond to the COVID-19 pandemic : Pfizer Inc

 

We are committed to doing all we can to respond to the COVID-19 pandemic and engaged with BioNTech on a potential coronavirus vaccine.

Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they're developing jointly is on target to be submitted for regulatory review in early October, as they released additional data from an early-stage study.

The companies stated that the vaccine was well tolerated in less than 20% of participants with mild to moderate fever. They said the companies continued to release data from Phase I trials in the US and Germany.

Confirmation of their October goal, previously announced last month, would make the vaccine the fastest-paced in the world.

Some analysts expect the use of the vaccine to be approved in the US by November.

Pfizer and BioNTech signed a $2 billion deal last month to supply the initial 100 million doses of the vaccine.

experimental candidates in hopes of stabilizing local economies and preventing the spread of the virus which has already taken 800,000 lives globally.

Comments

Popular posts from this blog

Beijing to implement stricter Covid-19 restrictions to help contain virus ahead of Lunar New Year 

Beijing has announced that it will require people travelling to the city from low-risk areas of China to present a negative Covid-19 test, as part of a raft of measures introduced ahead of the Lunar New Year celebrations. The restrictions will come into effect on January 28 and last until March 15, covering both the Lunar New Year festivities and the annual parliament meeting that occurs in the city. People who enter Beijing will have to undergo a 14-day health observation period, with a test taken on the seventh and 14th day after their arrival.  The spokesperson for Beijing’s city government, Xu Hejian, announced the new measures on Wednesday, over fears that travel during the holiday period could see people spread the virus around the country, causing a spike in cases. In recent weeks, areas around Beijing have seen Covid-19 restrictions increased since the start of the year, as authorities took a ‘wartime mode’ approach to prevent a wider outbreak occurring in Shijiazhuang ...

Workers or Warriors? Resident Doctors’ Protests and Health Governance in India

A health worker takes a break in front of a fan in New Delhi, August 2020. Photo: Reuters Even before COVID-19, protests by health workers in India were on the rise. According to one database, India had the most such protests in 85 countries between March 2019 and 2020. Most of them concerned unpaid salaries, poor management, contracts and regularisation, and patient overload, followed by protests around lack of supplies and equipment. Health workers have often faced uphill battles in having their demands met – but the underlying problem has been a lack of attention to health workers’ basic needs. One of the biggest casualties of the governance problems were medical entrance exams – a sphere in which NEET replaced the erstwhile faulty system with new problems. By now, many have watched the dramatic footage of junior doctors and police clashing in New Delhi or heard about ongoing demonstrations by resident doctors around India. These events have been taking place against the b...